Deubiquitinating enzyme CYLD regulates the peripheral development and naive phenotype maintenance of B cells. - Wikidata - wikimedia - TriplyDB

Deubiquitinating enzyme CYLD regulates the peripheral development and naive phenotype maintenance of B cells.

Deubiquitinating enzyme CYLD regulates the peripheral development and naive phenotype maintenance of B cells.

http://www.wikidata.org/entity/Q42510282

about

NF-κB in inflammation and renal diseases Does antigen masking by ubiquitin chains protect from the development of autoimmune diseases?Roles of the NF-kappaB pathway in lymphocyte development and function.Truncation of the deubiquitinating domain of CYLD in myelomonocytic cells attenuates inflammatory responses.SCFβ-TRCP regulates osteoclastogenesis via promoting CYLD ubiquitination.Tumor mapping in 2 large multigenerational families with CYLD mutations: implications for disease management and tumor induction.A reporter screen in a human haploid cell line identifies CYLD as a constitutive inhibitor of NF-κB.MicroRNA transcriptomes of distinct human NK cell populations identify miR-362-5p as an essential regulator of NK cell function CYLD-mediated signaling and diseases.Update of cylindromatosis gene (CYLD) mutations in Brooke-Spiegler syndrome: novel insights into the role of deubiquitination in cell signaling Deubiquitinating enzyme CYLD negatively regulates RANK signaling and osteoclastogenesis in mice.Tumor suppressor cylindromatosis acts as a negative regulator for Streptococcus pneumoniae-induced NFAT signaling A new look at T cell receptor signaling to nuclear factor-κB Truncation of the catalytic domain of the cylindromatosis tumor suppressor impairs lung maturation Deubiquitylation and regulation of the immune response.CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes.Synergistic and feedback signaling mechanisms in the regulation of inflammation in respiratory infections.Deubiquitinases in the regulation of NF-κB signaling.Emerging role of ubiquitination in antiviral RIG-I signaling Regulation of NF-κB by deubiquitinases.NF-κB function in B lymphocytes.Ubiquitylation in immune disorders and cancer: from molecular mechanisms to therapeutic implications.Immune diseases caused by mutations in kinases and components of the ubiquitin system.Signaling mechanisms regulating B-lymphocyte activation and tolerance.Roles of the NF-κB Pathway in B-Lymphocyte Biology.CYLD, A20 and OTULIN deubiquitinases in NF-κB signaling and cell death: so similar, yet so different.Wnt signalling pathways in chronic lymphocytic leukaemia and B-cell lymphomas.A novel missense mutation of the CYLD gene identified in a Hungarian family with Brooke-Spiegler syndrome.Inhibition of Ubc13-mediated Ubiquitination by GPS2 Regulates Multiple Stages of B Cell Development.Clinical significance of down-regulated cylindromatosis gene in chronic lymphocytic leukemia.New insights into NF-kappaB regulation and function.Immune Regulation by Ubiquitin Tagging as Checkpoint Code.Nuclear Factor-kappaB in Autoimmunity: Man and Mouse.Functional nature of a novel mutant CYLD observed in pediatric lymphoblastic B-cell leukemia.

P2860

Q27021276-68A860A0-F9EF-4A0A-B28D-DC9A067BE640 Q28387136-E3F7FCB4-C93D-4910-92B8-8B759C63F442 Q33800318-60002E16-9570-4F81-9389-3FF285B0FF22 Q33809154-5B5B426B-3E6F-43D9-896B-3F1BC16B6869 Q34100910-890AE254-B700-49DB-B774-4F0C50D85AC6 Q34111461-3A467ACA-4F6C-4D8C-8AAA-D99CDB176A8F Q34828781-9C05C06C-F004-4133-95A3-958D366EFF13 Q35535497-AF80DEFD-F94D-4236-A553-105FACB52CF2 Q35565726-1A19AF30-F0CA-4875-B5F1-DE9966AA4972 Q35625506-8F740B5B-7D1D-4BC5-A798-B6BD1ECF53F3 Q36512214-9C351CDB-ECA8-46AD-A5FC-5773D184CB75 Q36585593-CF8949CB-281B-4CD0-B173-5437D3444C53 Q36906449-174E25AC-0B12-4150-B50A-BBBC7C605BEC Q37165388-C5A252CD-4C1D-42F1-BA0E-E86EE7E0F04C Q37184075-CFB0052D-8DF7-4AA7-9DA6-E90AE5BEA488 Q37448141-26C17A32-291D-41ED-9974-4C10E2B9554E Q37728927-0005DBC2-BC54-4648-B580-4BADA6B3E4FE Q37814068-98F705A4-AE9F-4FE6-A409-488481E164C7 Q37990630-DFE78ADE-3B8A-4A82-AF0A-8FFD411E4F15 Q37995682-E4328B80-404A-4346-B86A-A530B40F7352 Q37995689-3351BC86-98DE-4705-A20E-2583B605744A Q38021448-8D1D5BDD-88C0-4F23-8CD2-A8A14D8F9A0C Q38212818-D1B940DF-1441-416B-9CED-B12EC05B0E6F Q38334794-11DD4BB7-EAC2-4E15-84B8-6FFE5D67C354 Q38567094-B3526AEC-8F5A-4D37-AD22-3A10B1C67506 Q39210955-B36022C5-B926-4EB5-A3EF-B85BFE83BB97 Q39432317-2AA6139E-7EF4-4A75-A443-E6265C4DB5AC Q43877768-A738B275-DB29-4B00-8186-7D5E8EF92E73 Q43892008-96EF35C9-132C-4560-9BAF-EF80CFF58D08 Q46030980-154F4294-6C3B-4413-97B4-892E25042FFC Q47097632-EE03DE70-399F-4E86-B7F9-E411A32B2710 Q47774246-B766B0AF-F0BD-4FB4-A13B-B28D21906BCF Q52311688-18583A22-2F10-4C34-A9B3-23E171D585EC Q52970760-38744044-981A-4F43-9736-FEBF8241D80A

P2860

Deubiquitinating enzyme CYLD regulates the peripheral development and naive phenotype maintenance of B cells.

http://www.wikidata.org/entity/Q42510282

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

Deubiquitinating enzyme CYLD r ...... notype maintenance of B cells.

@en

Deubiquitinating enzyme CYLD r ...... notype maintenance of B cells.

@nl

type

label

Deubiquitinating enzyme CYLD r ...... notype maintenance of B cells.

@en

Deubiquitinating enzyme CYLD r ...... notype maintenance of B cells.

@nl

prefLabel

Deubiquitinating enzyme CYLD r ...... notype maintenance of B cells.

@en

Deubiquitinating enzyme CYLD r ...... notype maintenance of B cells.

@nl

P1433

Q42510282-8B52DCB3-9A5D-4E20-A391-2C7075481DD8

P1476

Q42510282-12755796-C5CC-4D7C-9950-23E172C669E3

P2093

Q42510282-6D21C640-5ED3-4D05-A4E7-5520D3356369

Q42510282-73553860-ACB8-476B-AD25-0346886CB906

Q42510282-838A4CBD-6BA1-4670-9FA0-0F85F1A3AF98

Q42510282-A78DCEAE-C78F-4909-8A10-5D4F4132FD41

Q42510282-B758D486-9D0B-49FA-AE78-7158B59D386D

Q42510282-EB6651CD-3569-4D3A-8469-DBB6D7E9AFA5

Q42510282-F6DD9F5A-BA09-442D-A28B-2E621C14E05C

P2860

Q42510282-06A4CD1B-BA71-4AFC-AB2E-CA41B43951DB

Q42510282-0AB5DE68-9326-457F-8C6A-907727C40042

Q42510282-114B6D01-BD69-4BD4-A756-DC859DBF2FE7

Q42510282-151793C3-BB24-4F39-BF5A-F1D0F3965D12

Q42510282-1684D588-A135-4B70-8148-09318C4A2592

Q42510282-1719E1A8-192A-4B4F-ADE8-05D1B24EC785

Q42510282-24FD75E1-143B-4DFB-93EF-F6C24F4D22D3

Q42510282-3D966A47-6701-4E71-9526-612CDE841F9E

Q42510282-3F10FAF8-F186-49A4-B9FC-E749571BA83E

Q42510282-3FAC3BD6-1EDD-40A5-ACDC-C921A71A296C

P304

Q42510282-E045003B-E0F0-47BD-8B6A-B236D278F6D5

P31

Q42510282-D6EB7535-48DA-45DF-81CE-043D86AC2E1B

P356

Q42510282-267FC490-D879-46F4-AF39-5527B6C46BE9

P407

Q42510282-6235D3AE-A002-470F-BAC9-12F3DA61BAAF

P433

Q42510282-5ABA7FC8-CE15-4ECC-BCE4-1AA0490BB71E

P478

Q42510282-DCB8794C-E3DC-4F2B-B18C-96BE2E546486

P577

Q42510282-B9554EAE-275A-4158-9947-2D4F15B707AD

P698

Q42510282-537F738D-1847-44DD-99D4-D1CA237ED690

P356

P1433

Journal of Biological Chemistry

P1476

Deubiquitinating enzyme CYLD r ...... notype maintenance of B cells.

@en

P2093

Andrew J Lee

http://www.w3.org/2001/XMLSchema#string

Ato Wright

http://www.w3.org/2001/XMLSchema#string

Minying Zhang

http://www.w3.org/2001/XMLSchema#string

Shao-Cong Sun

http://www.w3.org/2001/XMLSchema#string

Wei Jin

http://www.w3.org/2001/XMLSchema#string

William R Reiley

http://www.w3.org/2001/XMLSchema#string

Xuefeng Wu

http://www.w3.org/2001/XMLSchema#string

P2860

I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding

NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway

The tumor suppressor CYLD interacts with TRIP and regulates negatively nuclear factor kappaB activation by tumor necrosis factor

BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2

Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells

Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity

Identification of the familial cylindromatosis tumour-suppressor gene

NF-kappaB1/p105 regulates lipopolysaccharide-stimulated MAP kinase signaling by governing the stability and function of the Tpl2 kinase

CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members

Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB

P304

15884-15893

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M609952200

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

282

http://www.w3.org/2001/XMLSchema#string

P577

2007-03-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17392286

http://www.w3.org/2001/XMLSchema#string